professional documents
home
Upload
docsters
Upload

search results


FDA ESG User Guide

GovernmentDocs 5/5/2008 | 0 (0) | 75 | 3 | 0 | English

FDA Electronic Submissions Gateway (ESG)User Guide November 20, 2007Table Of Contents1 Introduction  ... more>>

Transcript of FDA Press Conference on FDAAA

GovernmentDocs 5/5/2008 | 0 (0) | 73 | 1 | 0 | English

FDA MEDIA TELECONFERENCE FOOD AND DRUG ADMINISTRATION AMENDMENTS ACT OF 2007 Sept. 27, 2007, 2 p.m. EDT Coordinator: Welcome and thank you for standing by. At this time all parties are in a  ... more>>

DOCUMENT INFORMATION PAGE This page is for FDA FDA Table of Contents

FDADocs 5/9/2008 | 0 (0) | 71 | 1 | 0 | English

DOCUMENT INFORMATION PAGEThis page is for FDA internal use only. Do NOT send this page with the... revisions listed in the letter. SNDA-H4 AE RT/October 11, 2005C:\Documents and Settings\TAYLORR  ... more>>

FDA and Industry Actions on Premarket Approval Applications PMAs Effect on FDA Review Clock and Performance Assessment Guidance for Industry and FDA Staff

GovernmentDocs 5/4/2008 | 0 (0) | 70 | 0 | 0 | English

Guidance for Industry and FDA Staff FDA and Industry Actions on Premarket Approval Applications (PMAs): Effect on FDA Review Clock and Performance AssessmentDocument Issued on: October 8, 2003For  ... more>>

FDA Approved Labeling Text for NDA S S detailed view

FDADocs 5/9/2008 | 0 (0) | 70 | 0 | 0 | English

FDA Approved Labeling Text for NDA 21-717/S-005 & S-008 FINAL-Label-23-JAN-2004 PROVIGIL?? (modafinil) Tablets [C-IV] DESCRIPTION PROVIGIL (modafinil) is a wakefulness-promoting agent for oral  ... more>>

FDA Labeling Supplement Approval Letter

GovernmentDocs 5/5/2008 | 0 (0) | 68 | 1 | 0 | English

DEPARTMENT OF HEALTH & HUMAN SERVICESPublic Health ServiceFood and Drug Administration Rockville, MD 20857NDA 18-662/S046Hoffman-La Roche Inc. Attention: Joanna Wau...  ... more>>

FDA Backgrounder March a m Session

FDADocs 5/9/2008 | 0 (0) | 67 | 1 | 0 | English

Evaluation of Biotechnology-Derived Pharmaceuticals (July 1997) (http://www.fda.gov/cder/guidance  ... more>>

FDA Dermatology Consult Luke FDA Table of Contents

FDADocs 5/9/2008 | 0 (0) | 66 | 0 | 0 | English

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health ServiceDivision of Dermatologic and Dental Drug Products Office of Drug Evaluation V Center for Drug Evaluation and Research F...  ... more>>

CARRIER S RECEIPT FOR SAMPLE FDA

FDADocs 5/9/2008 | 0 (0) | 63 | 0 | 0 | English

DISTRICT ADDRESS AND PHONE NO.DEPARTMENT OF HEALTH AND HUMAN SERVICESFOOD AND DRUG ADMINISTRATIONNAME AND TITLE OF INDIVIDUAL300 S. Riverside Plaza, Suite 550 South Chi...  ... more>>

FDA Prescription Drug Labeling Script

FDADocs 5/9/2008 | 0 (0) | 62 | 1 | 0 | English

Script - An Introduction to the Improved FDA Prescription Drug LabelingWelcome and thank you for participating in the Food and Drug Administration, Center for Drug Evaluation and Research  ... more>>

FDA Dermatology Consult Porres FDA Table of Contents

FDADocs 5/9/2008 | 0 (0) | 61 | 1 | 0 | English

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health ServiceDivision of Dermatologic and Dental Drug Products Office of Drug Evaluation III Center for Drug Evaluation and Research...  ... more>>

FDA Forum handheld Doppler safety

FDADocs 5/9/2008 | 0 (0) | 61 | 0 | 0 | English

FDA Forum handheld Doppler safetyPage 1FDA Forum handheld Doppler safetyPage 2FDA Forum handheld Doppler safetyPage 3FDA Forum handheld Doppler safetyPage 4FDA  ... more>>

FDA Regulations and Recommendations for Failure Investigations

FDADocs 5/5/2008 | 0 (0) | 61 | 1 | 0 | English

FDA Regulations and Recommendations for Failure InvestigationsHoi-may Wong, BS, MT(ACSP)SBB Blood and Plasma Branch Division of Blood Applications, FDA, CBER, OBRRFDA Workshop Licensure of  ... more>>

Comprehensive List of CDER Guidance Documents

GovernmentDocs 5/4/2008 | 0 (0) | 61 | 0 | 0 | English

Center For Drug Evaluation and Research List of Guidance DocumentsGuidance documents represent... or on any person and do not operate to bind FDA or the public. An alternative approach may be used if  ... more>>

FDA Labeling Supplement Approval Letter

GovernmentDocs 5/5/2008 | 0 (0) | 61 | 0 | 0 | English

NDA 20-895/S-003Pfizer Inc Attention: Rita Wittich Director, Regulatory Affairs 235 East 42nd Street New York, NY 10017Dear Ms. Wittich: Please refer to your supplemental n...  ... more>>


   
  results / page   15/25/50 Page: 3 of 33 << prev 123456...33 next >>